Page last updated: 2024-08-25

alantolactone and Liver Neoplasms

alantolactone has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad Khan, MK; Khan, M; Li, T; Ma, T; Nawaz, F; Rasul, A; Sun, M; Zheng, Y1
Lei, JC; Liu, YW; Yin, Y; Yu, JQ; Zou, GL1

Other Studies

2 other study(ies) available for alantolactone and Liver Neoplasms

ArticleYear
Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction.
    BioMed research international, 2013, Volume: 2013

    Topics: Acetylcysteine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Glutathione; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation

2013
Alantolactone induces activation of apoptosis in human hepatoma cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2012, Volume: 50, Issue:9

    Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 8; Cytochromes c; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Poly(ADP-ribose) Polymerases; Sesquiterpenes, Eudesmane

2012